Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.

Breast Cancer Res Treat 2019 Aug 21;176(3):631-635. Epub 2019 May 21.

Department of Integrated Science and Engineering, Chuo University, Tokyo, Japan.

Purpose: While some studies show improved outcomes in clinical trial participants as compared to non-participants, existence of such a trial effect has not been proved precisely.

Methods: This was a prospective cohort study to compare the prognoses for participants in the randomized controlled trial (SELECT BC) and non-participants. SELECT BC compared S-1 and taxane as first-line treatment for metastatic breast cancer. Non-participants were all patients who met the eligibility criteria of SELECT BC and who had been requested to participate in that trial by attending doctors and declined. The study aimed to compare the prognoses between participants and non-participants. The primary endpoint was median overall survival.

Results: The median OS in participants was significantly superior to that in non-participants with a statistically significant difference (36.8 months vs. 25.2 months. HR 1.48, p = 0.022). A similar result was obtained when only patients who received the same chemotherapy (S-1 or taxane) used in SELECT BC after declining participation were assumed as non-participants (36.8 months vs. 22.0 months. HR 2.03, p = 0.006).

Conclusions: This study may suggest the existence of a trial effect, in which, for a given treatment, participation in a clinical trial is associated with a better outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05276-yDOI Listing
August 2019
1 Read

Publication Analysis

Top Keywords

clinical trial
8
cohort study
8
s-1 taxane
8
prospective cohort
8
existence trial
8
controlled trial
8
participants randomized
8
prognoses participants
8
randomized controlled
8
compare prognoses
8
trial
7
non-participants
7
participants
5
superior non-participants
4
primary endpoint
4
non-participants primary
4
participants non-participants
4
participants superior
4
median participants
4
median survivalresults
4

References

(Supplied by CrossRef)

S Davis et al.
Cancer 1985

JA Udell et al.
JAMA 2014

C Tanai et al.
Br J Cancer 2009

D Keizman et al.
Cancer Res Treat 2016

JM Peppercorn et al.
Lancet 2004

T Takashima et al.
Lancet Oncol 2016

H Mukai et al.
Jpn J Clin Oncol 2014

Similar Publications